Driehaus Capital Management’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.71M | Sell |
510,779
-584,754
| -53% | -$7.68M | 0.05% | 290 |
|
|
2025
Q1 | $15.8M | Sell |
1,095,533
-502,650
| -31% | -$7.23M | 0.15% | 191 |
|
|
2024
Q4 | $26.8M | Sell |
1,598,183
-563,545
| -26% | -$9.44M | 0.22% | 139 |
|
|
2024
Q3 | $34.6M | Buy |
2,161,728
+69,717
| +3% | +$1.11M | 0.3% | 109 |
|
|
2024
Q2 | $18.9M | Buy |
2,092,011
+987,997
| +89% | +$8.92M | 0.18% | 158 |
|
|
2024
Q1 | $12.5M | Buy |
1,104,014
+814,633
| +282% | +$9.21M | 0.12% | 214 |
|
|
2023
Q4 | $2.3M | Buy |
+289,381
| New | +$2.3M | 0.03% | 292 |
|
|
2022
Q2 | – | Sell |
-1,053,142
| Closed | -$9.45M | – | 375 |
|
|
2022
Q1 | $9.45M | Sell |
1,053,142
-32,555
| -3% | -$292K | 0.12% | 241 |
|
|
2021
Q4 | $12.2M | Buy |
1,085,697
+66,897
| +7% | +$753K | 0.12% | 219 |
|
|
2021
Q3 | $17M | Buy |
1,018,800
+18,939
| +2% | +$316K | 0.2% | 156 |
|
|
2021
Q2 | $22.2M | Buy |
+999,861
| New | +$22.2M | 0.29% | 114 |
|